{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:28:50Z","timestamp":1773030530051,"version":"3.50.1"},"reference-count":33,"publisher":"Sociedad Espanola de Patologia Digestiva (SEPD)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Enferm Dig"],"published-print":{"date-parts":[[2020]]},"DOI":"10.17235\/reed.2020.6508\/2019","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T10:22:19Z","timestamp":1587464539000},"source":"Crossref","is-referenced-by-count":2,"title":["Factors associated with the presence of abnormal levels of fecal calprotectin in patients with negative panenteric studies"],"prefix":"10.17235","volume":"112","author":[{"given":"Juan","family":"Egea Valenzuela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Iglesias Jorquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"\u00c1lvarez-Higueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mu\u00f1oz Tornero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Pere\u00f1\u00edguez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Estrella D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Alberca de las Parras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6910","reference":[{"key":"ref1","unstructured":"1. D\ufffdAngelo F, Felley C, Frossard JL. Calprotectin in Daily Practice: Where Do We Stand in 2017? Digestion 2017; 95: 293-301."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2016.04.009"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618784046"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Brookes MJ, Whitehead S, Gaya DR, et al. Practical guidance on the use of faecal calprotectin. Frontline Gastroenterol 2018; 9: 87-91.","DOI":"10.1136\/flgastro-2016-100762"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Aziz M, Melchior C, Zalar A, et al. Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study. United Eur Gastroenterol J 2016; 5: 261\ufffd9.","DOI":"10.1177\/2050640616650062"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.551835"},{"key":"ref7","unstructured":"7. Egea-Valenzuela J, Alberca-de-las-Parras F, Carballo-\u00c1lvarez F. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy. Rev Esp Enferm Dig 2015; 107: 211-4."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000692"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1253769"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy098"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2015.12.008"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2018.10.010"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3369"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2016.4318\/2016"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1566493"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00074"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2014.1786"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1462-2920.12934"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3AB0815-379RR"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000639"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2016.105"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5120118"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.907326"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.020"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1066421"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.14712\/18059694.2016.56"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200305000-00021"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Guslandi M. Steroid ulcers: Any news? World J Gastrointest Pharmacol Ther 2013; 4: 39\ufffd40.","DOI":"10.4292\/wjgpt.v4.i3.39"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.04.003"},{"key":"ref30","unstructured":"30. Fundar\u00f2 C, Fantacci C, Ansuini V, et al. Fecal calprotectin concentration in children affected by SIBO. Eur Rev Med Pharmacol Sci 2011;15:1328\ufffd35."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000116777"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.15386\/cjmed-303"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2018.11.004"}],"container-title":["Revista Espa\u00f1ola de Enfermedades Digestivas"],"original-title":[],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:37:42Z","timestamp":1615336662000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=686767740231-415278191162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":33,"URL":"https:\/\/doi.org\/10.17235\/reed.2020.6508\/2019","relation":{},"ISSN":["1130-0108"],"issn-type":[{"value":"1130-0108","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}